Epilepsy and Seizure News
Neurofeedback News
Camelback Recovery Launches Neurofeedback Therapy at Its Phoenix Treatment Center -
Camelback Recovery has launched neurofeedback therapy at its Phoenix treatment center, expanding the care options available within its mental health and addiction programs. Phoenix, Arizona--(Newsfile ...
How virtual reality is changing brain-training technology -
Integrating virtual reality into brain-training therapies can make the experience more enjoyable and engaging for users. A recent review published in the journal Applied Psychophysiology and ...
What Is Neurofeedback Therapy? -
Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...
Muse Treatment Publishes New Neurofeedback Resource Following 2026 Addiction Research and Changing Overdose Trends -
LOS ANGELES, CA - September 14, 2026 - PRESSADVANTAGE - Muse Treatment has published a new educational resource ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
Medical News Today
PubMed
Clobazam and Valproate, but Lamotrigine, a Sodium Channel Inhibitor, Reduce the Incidence of Hyperthermia-Induced Clonic Seizures in Dravet Syndrome Mice: Assessment of Anti-Seizure Effects in Mice... -
CONCLUSION: These results reflect clinical findings that CLB and VPA suppress, but LTG does not suppress seizures in patients with DS. Our data demonstrate the validity of our test system to induce hyperthermia-induced seizures and to evaluate the efficacy of antiseizure medications in Scn1a KI/+ mice.
International Federation of Clinical Neurophysiology standardized stereo-electroencephalography terminology -
CONCLUSION: This IFCN guideline establishes standardized SEEG terminology to promote consistent interpretation and multicenter collaboration.
VENI, VIDI, VICI: The advantage of early epilepsy surgery in drug-sensitive patients -
OBJECTIVE: Surgical intervention is frequently considered for drug-resistant focal structural epilepsy. However, the impact of early surgery on seizure control, cognitive performance, and quality of life (QoL) across drug-sensitive and drug-resistant patients remains incompletely characterized.
Bi-allelic GAD2 variants cause a rare developmental encephalopathy with early-onset seizures -
CONCLUSION: Our findings firmly establish GAD2 as a disease gene implicated in developmental encephalopathy with early-onset seizures. The concordance between the human phenotype and the characteristics of the knockout mouse model emphasizes the pivotal role of GAD2 in neurodevelopment and epilepsy.
Discovery of Novel Bicyclic Pyrazole Amides as Potent Neuronal KV7 Potassium Channel Openers with Strong Preclinical Antiseizure Activity -
There has been considerable interest in developing openers of neuronal K(V)7 potassium channels, particularly K(V)7.2 (KCNQ2) and K(V)7.3 (KCNQ3), as both genetic and clinical evidence strongly support their therapeutic potential in seizure disorders. Herein, we describe the discovery of a series of neuronal K(V)7 potassium channel openers, optimized primarily via conformational rigidification ...
Association of a Dietary Index for Gut Microbiota With Epilepsy Among US Adults Aged 40 and Over: A Cross-Sectional Study -
CONCLUSIONS: Higher DI-GM adherence was associated with lower odds of prevalent epilepsy, particularly in metabolically healthier subgroups. Prospective and intervention studies are needed to test temporality and clinical relevance.
Science Daily